Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

© Synapse Social LLC, 2026

Política de privacidad

May 15, 2026Open Access

Analytical technology transfer for mRNA vaccine quality control

Puntos clave

The aim is to enhance the quality control processes for mRNA vaccines through analytical technology transfer.
Engagement with external authors for publication.
Participation in the International Symposium on Immunobiologicals.
Coordination by the Instituto de Tecnologia em Imunobiológicos.
Recommendations for improving quality control in mRNA vaccines based on discussions at the symposium.

Resumen

Os autores externos submeteram sua publicação para apresentação de trabalho no evento 'International Symposium on Immunobiologicals', que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Azevedo et al. (Thu,) studied this question.

synapsesocial.com/papers/6a06b983e7dec685947ac2f8 https://doi.org/https://doi.org/10.35259/isi.2026_76260

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Implementation of documents and workflow for internal technology transfer of analytical methods at LATIM in development of an mRNA COVID-19 vaccine2026
2Development and analytical qualification of a cell-based potency assay for mRNA COVID-19 vaccines2026
3Method qualification for the assessment of mRNA vaccine encapsulation efficiency2026
4Ensuring mRNA vaccine identity: qualification of an RT-qPCR assay for COVID-19 vaccine verification2026
5Analytical Monitoring of mRNA integrity under storage and freeze-thaw conditions2026

Transferencia tecnológica analítica para el control de calidad de vacunas de ARNm | Synapse